The 9th TPD & Induced Proximity Summit 2026, will bring together the TPD and induced-proximity community across discovery, degrader optimisation, preclinical development, translational strategy, clinical development and emerging technologies.
TCG Lifesciences will be part of these conversations, bringing expertise in PROTAC and molecular-glue chemistry, linker and E3-ligand chemistry, analogue generation and PROTAC library synthesis, alongside in vitro pharmacology and DMPK capabilities including ADME and PK. TCGLS’s TPD platform leverages 25+ years of integrated drug discovery expertise and has supported the synthesis of 3,000+ membered PROTAC libraries, contributing to leads currently advancing through clinical trials.
Attendee: Dr. Sanjoy Kumar Mahanty, Vice President, Head of Business Development-NA
Connect with TCGLS at CPHI Milan 2026 as we collaborate with the global pharmaceutical community to drive innovation across the pharma value chain and accelerate the future of healthcare.
Book A MeetingMeet TCGLS at the 24th Annual Discovery on Target in Boston as we engage with global drug discovery leaders to explore the latest innovations in therapeutic discovery, AI-driven research, and next-generation drug modalities.
Book A MeetingJoin TCGLS at EFMC Medicinal Chemistry 2026 in Basel as we connect with the global medicinal chemistry community to advance innovation in drug discovery, chemical biology, and translational research.
Book A Meeting